ZYUS

About:

ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.

Website: https://www.zyus.com/

Twitter/X: ZYUSInc

Top Investors: Keyhorse Capital (KSTC)

Description:

ZYUS is a biopharmaceutical company that offers patients cannabinoids and other phytotherapeutic medical solutions. The company elevates cannabinoids as a medical solution to alleviate suffering in patients who are experiencing discomfort due to chronic disease, treatment side effects, or conditions related to aging. It aims is to shift the paradigm from the treatment of physical disease to caring for overall well-being, by accelerating the adoption of phytotherapeutics. The company uses science as a driver to establish phytotherapeutics as a standard of care for treating disease and managing the experience of it. The company was founded in 2018 and is headquartered in Saskatoon, Saskatchewan.

Total Funding Amount:

$36.9M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Saskatoon, Saskatchewan, Canada

Founded Date:

2018-01-01

Contact Email:

invest(AT)zyus.com

Founders:

Brent Zettl

Number of Employees:

1-10

Last Funding Date:

2024-09-27

IPO Status:

Public

Industries:

© 2025 bioDAO.ai